FDA七月重磅审评:阿尔兹海默症、骨髓瘤新药扎堆获批,两款基因/细胞疗法遭拒 -- 250730 episode artwork

EPISODE · Aug 3, 2025 · 4 MIN

FDA七月重磅审评:阿尔兹海默症、骨髓瘤新药扎堆获批,两款基因/细胞疗法遭拒 -- 250730

from 生物科技 · host Rei

2025年7月,美国FDA动作频频,不仅批准了多款创新疗法,也对几项备受关注的基因和细胞疗法投下否决票。这期我们为你梳理7月FDA的关键决策,包括阿尔兹海默症、骨髓瘤、罕见病等多个领域的重大进展,以及其中涉及的机制与药物基础,助你快速掌握药物监管新风向。

Episode metadata supplied by the publisher feed · Published Aug 3, 2025

Embed this episode

Ready to play

FDA七月重磅审评:阿尔兹海默症、骨髓瘤新药扎堆获批,两款基因/细胞疗法遭拒 -- 250730

0:00 4:46

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of 生物科技?

This episode is 4 minutes long.

When was this 生物科技 episode published?

This episode was published on August 3, 2025.

Can I download this 生物科技 episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!